According to the main investor in CureVac, there current plan is to make the vaccine generally available at the end of the year:
https://www.focus.de/finanzen/boerse/weil-biotech-leben-rettet-curevac-investor-im-fruehsommer-koennen-wir-mit-dem-test-des-impfstoffs-am-menschen-beginnen_id_11829181.html
According to the main investor in CureVac, there current plan is to make the vaccine generally available at the end of the year:
https://www.focus.de/finanzen/boerse/weil-biotech-leben-rettet-curevac-investor-im-fruehsommer-koennen-wir-mit-dem-test-des-impfstoffs-am-menschen-beginnen_id_11829181.html